▓▓▓▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒▒▒▒················
▓▓▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒▒▒·················
▓▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒▒··················
▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒···················
▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒····················
▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒·····················
▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒······················
▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒·······················
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━
NR507
ADVANCED PATHOPHYSIOLOGY
MIDTERM & FINAL EXAM
2026–2027 UPDATE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━
Verified Questions & Answers with Rationales | Graded A+
················· ◆ ◇ ◆
·················· ◆ ◆◆◆ ◆
··················· ◆◆ ◆ ◆◆
—1—
,
,Section 1: Introduction
This NR507 Advanced Pathophysiology Midterm and Final Exam document is a
comprehensive graduate-level resource aligned with current MSN/DNP advanced
pathophysiology curricula, evidence-based clinical science, and 2025–2026 updates.
Content spans cellular biology, genetics, immunology and inflammation, infectious disease,
cardiovascular, respiratory, neurologic, endocrine, renal, gastrointestinal, musculoskeletal,
hematologic, reproductive, and multisystem pathophysiologic processes.
Each question is presented in midterm/final examination format with four answer choices,
the correct answer highlighted in bold cyan, and a detailed rationale explaining the
pathophysiologic mechanism, characteristic clinical findings, and key distractors consistent
with advanced nursing practice expectations. The midterm covers foundational and
system-based pathophysiology; the final is cumulative with emphasis on integrated,
multisystem disease processes.
Section 2: Midterm Exam Questions (1–150)
1. Which type of cellular adaptation involves a decrease in cell size (and reduced functional
demand) in response to chronic under-stimulation, ischemia, or decreased workload?
A. Hypertrophy
B. Hyperplasia
C. Atrophy—reduced cell size with decreased protein synthesis and increased
autophagy
D. Metaplasia
Rationale: Atrophy is a reversible adaptive decrease in cell size and functional capacity
caused by disuse, denervation, ischemia, malnutrition, loss of endocrine stimulation, or
aging. It involves decreased protein synthesis, increased catabolism (ubiquitin-
proteasome pathway), and increased autophagy.
2. In response to chronic irritation (e.g., cigarette smoke in the respiratory tract), which
adaptive change replaces one mature cell type with another that is better suited to the
stress?
A. Dysplasia
B. Atrophy
C. Hypertrophy
D. Metaplasia—reversible replacement of one differentiated cell type by
another (e.g., columnar epithelium replaced by stratified squamous in smokers)
, Rationale: Metaplasia is a reversible adaptive substitution of one cell type for another in
response to chronic irritation, such as the replacement of ciliated columnar epithelium
with stratified squamous epithelium in the bronchi of smokers. While initially protective,
metaplasia can progress to dysplasia and cancer if the stimulus persists.
3. The most common form of cell death in hypoxic/ischemic injury, characterized by
cellular swelling, organelle breakdown, membrane rupture, and inflammation is:
A. Apoptosis
B. Autophagy
C. Pyroptosis
D. Necrosis—confluent cell death with loss of membrane integrity and
subsequent inflammation
Rationale: Necrosis is the pathological, unprogrammed death of cells due to severe injury
(ischemia, toxins, trauma). It features ATP depletion, cellular swelling, Ca2+ influx,
membrane breakdown, release of intracellular contents, and an acute inflammatory
response—hallmarks that distinguish it from apoptosis.
4. Programmed, organized cell death without inflammation (e.g., removal of cells during
embryonic development or in damaged cells that cannot be repaired) is termed:
A. Necrosis
B. Apoptosis—regulated cell death with cell shrinkage, chromatin
condensation, apoptotic body formation, and phagocytosis without inflammation
C. Metaplasia
D. Oncosis
Rationale: Apoptosis is programmed cell death that does not rupture cell membranes;
cells shrink, chromatin condenses, plasma membranes form blebs/apoptotic bodies that
are phagocytized, and no inflammatory response occurs. It is essential in development,
immune tolerance, tumor surveillance, and removal of irreparably damaged cells.
5. Caseous necrosis, classically associated with tuberculosis, is characterized by:
A. Preserved tissue architecture (coagulative)
B. Liquefaction of tissue in abscesses/brain infarcts
C. Cheese-like, granular debris from granulomatous inflammation
(combination of coagulative and liquefactive necrosis) walled off by granulomas
D. Fat destruction from pancreatitis
Rationale: Caseous necrosis appears as soft, granular, 'cheese-like' tissue, characteristic
of granulomatous infection with Mycobacterium tuberculosis. It represents a mixture of
▓▓▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒▒▒·················
▓▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒▒··················
▓▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒▒···················
▓▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒▒····················
▓▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒▒·····················
▓▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒▒······················
▓░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░▒·······················
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━
NR507
ADVANCED PATHOPHYSIOLOGY
MIDTERM & FINAL EXAM
2026–2027 UPDATE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━━━━━━━━━
Verified Questions & Answers with Rationales | Graded A+
················· ◆ ◇ ◆
·················· ◆ ◆◆◆ ◆
··················· ◆◆ ◆ ◆◆
—1—
,
,Section 1: Introduction
This NR507 Advanced Pathophysiology Midterm and Final Exam document is a
comprehensive graduate-level resource aligned with current MSN/DNP advanced
pathophysiology curricula, evidence-based clinical science, and 2025–2026 updates.
Content spans cellular biology, genetics, immunology and inflammation, infectious disease,
cardiovascular, respiratory, neurologic, endocrine, renal, gastrointestinal, musculoskeletal,
hematologic, reproductive, and multisystem pathophysiologic processes.
Each question is presented in midterm/final examination format with four answer choices,
the correct answer highlighted in bold cyan, and a detailed rationale explaining the
pathophysiologic mechanism, characteristic clinical findings, and key distractors consistent
with advanced nursing practice expectations. The midterm covers foundational and
system-based pathophysiology; the final is cumulative with emphasis on integrated,
multisystem disease processes.
Section 2: Midterm Exam Questions (1–150)
1. Which type of cellular adaptation involves a decrease in cell size (and reduced functional
demand) in response to chronic under-stimulation, ischemia, or decreased workload?
A. Hypertrophy
B. Hyperplasia
C. Atrophy—reduced cell size with decreased protein synthesis and increased
autophagy
D. Metaplasia
Rationale: Atrophy is a reversible adaptive decrease in cell size and functional capacity
caused by disuse, denervation, ischemia, malnutrition, loss of endocrine stimulation, or
aging. It involves decreased protein synthesis, increased catabolism (ubiquitin-
proteasome pathway), and increased autophagy.
2. In response to chronic irritation (e.g., cigarette smoke in the respiratory tract), which
adaptive change replaces one mature cell type with another that is better suited to the
stress?
A. Dysplasia
B. Atrophy
C. Hypertrophy
D. Metaplasia—reversible replacement of one differentiated cell type by
another (e.g., columnar epithelium replaced by stratified squamous in smokers)
, Rationale: Metaplasia is a reversible adaptive substitution of one cell type for another in
response to chronic irritation, such as the replacement of ciliated columnar epithelium
with stratified squamous epithelium in the bronchi of smokers. While initially protective,
metaplasia can progress to dysplasia and cancer if the stimulus persists.
3. The most common form of cell death in hypoxic/ischemic injury, characterized by
cellular swelling, organelle breakdown, membrane rupture, and inflammation is:
A. Apoptosis
B. Autophagy
C. Pyroptosis
D. Necrosis—confluent cell death with loss of membrane integrity and
subsequent inflammation
Rationale: Necrosis is the pathological, unprogrammed death of cells due to severe injury
(ischemia, toxins, trauma). It features ATP depletion, cellular swelling, Ca2+ influx,
membrane breakdown, release of intracellular contents, and an acute inflammatory
response—hallmarks that distinguish it from apoptosis.
4. Programmed, organized cell death without inflammation (e.g., removal of cells during
embryonic development or in damaged cells that cannot be repaired) is termed:
A. Necrosis
B. Apoptosis—regulated cell death with cell shrinkage, chromatin
condensation, apoptotic body formation, and phagocytosis without inflammation
C. Metaplasia
D. Oncosis
Rationale: Apoptosis is programmed cell death that does not rupture cell membranes;
cells shrink, chromatin condenses, plasma membranes form blebs/apoptotic bodies that
are phagocytized, and no inflammatory response occurs. It is essential in development,
immune tolerance, tumor surveillance, and removal of irreparably damaged cells.
5. Caseous necrosis, classically associated with tuberculosis, is characterized by:
A. Preserved tissue architecture (coagulative)
B. Liquefaction of tissue in abscesses/brain infarcts
C. Cheese-like, granular debris from granulomatous inflammation
(combination of coagulative and liquefactive necrosis) walled off by granulomas
D. Fat destruction from pancreatitis
Rationale: Caseous necrosis appears as soft, granular, 'cheese-like' tissue, characteristic
of granulomatous infection with Mycobacterium tuberculosis. It represents a mixture of
